SC
EUCRU

Sculptor Capital’s Eucrates Biomedical Acquisition Corp. Unit EUCRU Stock Holding History

Sculptor Capital’s Portfolio EUCRU Stock Details EUCRU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-7
Closed – – 991
2022
Q3 		$0 Hold
7
– – ﹤0.01% 1237
2022
Q2 		$0 Sell
7
-79,143
-100% -$786K ﹤0.01% 1321
2022
Q1 		$780K Buy
+79,150
New +$785K 0.01% 715

Other funds holding EUCRU

Verition Fund Management
Verition Fund Management Greenwich, Connecticut $10.3B AUM 30.69% 1-Year Est. Return
SCM
Sio Capital Management New York $694M AUM 79.73% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $6.41B AUM 4.78% 1-Year Est. Return
CS
Clear Street New York $17.8B AUM 56.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return